Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease encephalopathy
Comorbidity C0023890|liver cirrhosis
Sentences 30
PubMedID- 25459346 Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
PubMedID- 25100119 Conclusion: probiotics decrease overt hepatic encephalopathy in patients with liver cirrhosis.
PubMedID- 21757988 This case shows that caution should be exercised when administering metronidazole because even a low dose can induce encephalopathy in patients with liver cirrhosis.
PubMedID- 21483460 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
PubMedID- 19903725 Standardized nomenclature has been proposed but a standardized approach to the treatment, particularly of persistent, episodic and recurrent encephalopathy associated with liver cirrhosis has not been proposed.
PubMedID- 23225825 Previously studies have investigated the effect of propofol on sub-clinical hepatic encephalopathy in patients with compensated liver cirrhosis.11,18 these studies found that propofol sedation during upper gastrointestinal endoscopy did not cause acute deterioration of sub-clinical hepatic encephalopathy.11,18 however, in patients with liver cirrhosis, hepatic function reserve is quite limited, and a cirrhotic liver is less tolerant to hemodynamic changes and surgical stress.1 therefore, anesthetic agents should be titrated with caution in cirrhotic patients to minimize the adverse effects of drugs and to stabilize hemodymanics.
PubMedID- 20642112 Low doses are used as a food supplement and high doses (above 5 g) as a medicinal product to lower blood ammonia concentration and to eliminate symptoms of hepatic encephalopathy associated with liver cirrhosis.
PubMedID- 25528831 [pathogenesis, diagnosis and treatment of hepatic encephalopathies in patients with liver cirrhosis].
PubMedID- 20852922 The mean cff was higher in patients after liver transplantation, but did not reach statistical significance.table 2surrogate markers for hepatic encephalopathy in patients with liver cirrhosis and those who have received liver transplants.
PubMedID- 24078984 Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis.
PubMedID- 22734925 Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: occlusion of portosystemic shunt in combination with splenectomy.
PubMedID- 20506574 Wernicke encephalopathy following splenectomy in a patient with liver cirrhosis: a case report and review of the literature.
PubMedID- 22384773 Minimal hepatic encephalopathy in patients with decompensated liver cirrhosis.
PubMedID- 20010298 Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis.
PubMedID- 25932262 Aim: to determine the effects of small-intestinal bacterial overgrowth (sibo) and rifaximin therapy on minimal hepatic encephalopathy (mhe) with liver cirrhosis.
PubMedID- 25509200 The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis.
PubMedID- 26516441 In our study, hyponatremia was associated with increased incidence of hepatic encephalopathy in patients with decompensated liver cirrhosis.
PubMedID- 20482828 Severe hepatic encephalopathy in a patient with liver cirrhosis after administration of angiotensin-converting enzyme inhibitor/angiotensin ii receptor blocker combination therapy: a case report.
PubMedID- 25674427 Supplementation with bcaas normalizes amino acid profiles, ameliorates complications such as encephalopathy and hypoalbuminemia in patients with liver cirrhosis (kawaguchi et al.
PubMedID- 25867912 Objective: to determine the efficacy of rifaximin once a day dose in the prevention of hepatic encephalopathy (he) in patients with liver cirrhosis as compared with twice daily dose of rifaximin.
PubMedID- 25420513 Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
PubMedID- 20216550 Increased blood-brain barrier (bbb) permeability for ammonia is considered to be an integral part of the pathophysiology of hepatic encephalopathy (he) in patients with liver cirrhosis.
PubMedID- 25847088 Aim: to examine whether the brain exhibits metabolic disorder prior to overt hepatic encephalopathy in patients with liver cirrhosis (lc), the intracerebral glutamine and myo-inositol levels were determined using 3.0-tesla (t)1 h (proton) magnetic resonance spectroscopy (mrs).
PubMedID- 20934771 Conclusions: sedation with propofol has a shorter time recovery and a shorter time to discharge than midazolam and does not exacerbate sub-clinical hepatic encephalopathy in patients with compensated liver cirrhosis.
PubMedID- 25863779 Patients with hepatic encephalopathy in liver cirrhosis and healthy controls ingested a 20-g solution of glutamine dissolved in 100 ml of tap water.
PubMedID- 24974838 Infection and liver cirrhosis: possible association with hepatic encephalopathy and/or post-hepatic encephalopathy cognitive impairment in patients with portal hypertension.
PubMedID- 21416318 Pylori) bacteria convert urea to ammonia, which has been implicated in causation of hepatic encephalopathy in patients with liver cirrhosis.
PubMedID- 24709242 Objective: to determine the efficacy of rifaximin in prevention of repeated episodes of hepatic encephalopathy in patients with liver cirrhosis as compared to placebo.
PubMedID- 22870180 In conclusion, we experienced mnz-induced encephalopathy developed in patients with liver cirrhosis.
PubMedID- 25060166 Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted mr imaging and proton mr spectroscopy of the brain.

Page: 1